Ma, Feiyang http://orcid.org/0000-0002-6260-0787
Tsou, Pei-Suen
Gharaee-Kermani, Mehrnaz
Plazyo, Olesya
Xing, Xianying
Kirma, Joseph
Wasikowski, Rachael http://orcid.org/0000-0003-3544-3023
Hile, Grace A.
Harms, Paul W. http://orcid.org/0000-0002-0802-2883
Jiang, Yanyun
Xing, Enze http://orcid.org/0000-0001-9358-9368
Nakamura, Mio
Ochocki, Danielle
Brodie, William D.
Pillai, Shiv http://orcid.org/0000-0002-9905-875X
Maverakis, Emanual
Pellegrini, Matteo http://orcid.org/0000-0001-9355-9564
Modlin, Robert L. http://orcid.org/0000-0003-4720-031X
Varga, John
Tsoi, Lam C.
Lafyatis, Robert http://orcid.org/0000-0002-9398-5034
Kahlenberg, J. Michelle http://orcid.org/0000-0002-4006-8945
Billi, Allison C. http://orcid.org/0000-0001-7115-9113
Khanna, Dinesh http://orcid.org/0000-0003-1412-4453
Gudjonsson, Johann E. http://orcid.org/0000-0002-0080-0812
Article History
Received: 27 February 2023
Accepted: 23 December 2023
First Online: 3 January 2024
Competing interests
: J.E.G. has received Grant support from Celgene/BMS, Janssen, Eli Lilly, and Almirall. J.E.G. has served on advisory boards for AstraZeneca, Sanofi, Eli Lilly, Boehringer Ingelheim, Novartis, Janssen, Almirall, BMS. J.M.K. has received Grant support from Q32 Bio, Celgene/BMS, Ventus Therapeutics, and Janssen. J.M.K. has served on advisory boards for AstraZeneca, Eli Lilly, GlaxoSmithKline, Bristol Myers Squibb, Avion Pharmaceuticals, Provention Bio, Aurinia Pharmaceuticals, Ventus Therapeutics, Vera Therapeutics, and Boehringer Ingelheim. P.W.H. has received effort support from Q32 Bio. The remaining authors declare no competing interests.